These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Quantitative ultrasound of bone and markers of bone turnover in Cushing's syndrome. Cortet B, Cortet C, Blanckaert F, d'Herbomez M, Marchandise X, Wémeau J-L, Decoulx M, Dewailly D. Osteoporos Int; 2001 Mar; 12(2):117-23. PubMed ID: 11303711 [Abstract] [Full Text] [Related]
10. Cushing's syndrome and bone mineral density: lowest Z scores in young patients. van der Eerden AW, den Heijer M, Oyen WJ, Hermus AR. Neth J Med; 2007 Apr; 65(4):137-41. PubMed ID: 17452762 [Abstract] [Full Text] [Related]
11. Phalangeal quantitative ultrasound technology and dual energy X-ray densitometry in patients with primary hyperparathyroidism: influence of sex and menopausal status. Camozzi V, Lumachi F, Mantero F, Piccolo M, Luisetto G. Osteoporos Int; 2003 Jul; 14(7):602-8. PubMed ID: 12730752 [Abstract] [Full Text] [Related]
12. Recovery of bone mineral density after surgical cure, but not by ketoconazole treatment, in Cushing's syndrome. Luisetto G, Zangari M, Camozzi V, Boscaro M, Sonino N, Fallo F. Osteoporos Int; 2001 Jul; 12(11):956-60. PubMed ID: 11804023 [Abstract] [Full Text] [Related]
13. Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing's disease. Di Somma C, Colao A, Pivonello R, Klain M, Faggiano A, Tripodi FS, Merola B, Salvatore M, Lombardi G. Clin Endocrinol (Oxf); 1998 May; 48(5):655-62. PubMed ID: 9666879 [Abstract] [Full Text] [Related]
14. The effects of cortisol and adrenal androgen on bone mass in Asians with and without subclinical hypercortisolism. Ahn SH, Kim JH, Cho YY, Suh S, Kim BJ, Hong S, Lee SH, Koh JM, Song KH. Osteoporos Int; 2019 May; 30(5):1059-1069. PubMed ID: 30719548 [Abstract] [Full Text] [Related]
15. The patients with incidentally discovered adrenal adenoma (incidentaloma) are not at increased risk of osteoporosis. Osella G, Reimondo G, Peretti P, Alì A, Paccotti P, Angeli A, Terzolo M. J Clin Endocrinol Metab; 2001 Feb; 86(2):604-7. PubMed ID: 11158016 [Abstract] [Full Text] [Related]
16. Evaluation of bone mineral density of the peripheral skeleton in pre- and postmenopausal women with newly diagnosed endogenous Cushing's syndrome. Karavitaki N, Ioannidis G, Giannakopoulos F, Mavrokefalos P, Thalassinos N. Clin Endocrinol (Oxf); 2004 Feb; 60(2):264-70. PubMed ID: 14725690 [Abstract] [Full Text] [Related]
17. Alterations of bone turnover and bone mass at different skeletal sites due to pure glucocorticoid excess: study in eumenorrheic patients with Cushing's syndrome. Chiodini I, Carnevale V, Torlontano M, Fusilli S, Guglielmi G, Pileri M, Modoni S, Di Giorgio A, Liuzzi A, Minisola S, Cammisa M, Trischitta V, Scillitani A. J Clin Endocrinol Metab; 1998 Jun; 83(6):1863-7. PubMed ID: 9626110 [Abstract] [Full Text] [Related]
18. Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome. Hermus AR, Smals AG, Swinkels LM, Huysmans DA, Pieters GF, Sweep CF, Corstens FH, Kloppenborg PW. J Clin Endocrinol Metab; 1995 Oct; 80(10):2859-65. PubMed ID: 7559865 [Abstract] [Full Text] [Related]
19. Quantitative ultrasound technology in evaluating bone status and osteoporosis in patients with Cushing's syndrome. Camozzi V, Luisetto G, Zangari M, Lumachi F. Ann N Y Acad Sci; 2007 Nov; 1117():352-6. PubMed ID: 17872385 [Abstract] [Full Text] [Related]
20. The prevalence of significant left-right differences in hip bone mineral density. Hamdy R, Kiebzak GM, Seier E, Watts NB. Osteoporos Int; 2006 Dec; 17(12):1772-80. PubMed ID: 17019523 [Abstract] [Full Text] [Related] Page: [Next] [New Search]